74,000多名临床试验参与者受到NIH资金削减的影响,影响到383项关于主要疾病的研究。 Over 74,000 clinical trial participants were impacted by NIH funding cuts affecting 383 studies on major diseases.

根据JAMA内部医学报告,参加临床试验的74 000多人受到国家卫生研究所资金削减的影响。 Over 74,000 people enrolled in clinical trials have been affected by funding cuts to the National Institutes of Health, according to a JAMA Internal Medicine report. 在2025年2月至8月期间,383项由NIH资助的研究(其中许多侧重于癌症、心脏病、脑疾病和传染病)丢失资金、中断研究、停止参与者护理和破坏潜在的医疗突破。 Between February and August 2025, 383 NIH-funded studies—many focused on cancer, heart disease, brain disorders, and infectious diseases—lost funding, disrupting research, halting participant care, and jeopardizing potential medical breakthroughs. 有些试验在中途取消,使参加者无法获得治疗或监测,而其他试验则从未完成,从而危及数据完整性和公众信任。 Some trials were canceled mid-way, leaving participants without access to treatments or monitoring, while others were never completed, risking data integrity and public trust. 这些削减是特朗普政府更广泛削减资金的一部分,与最高法院允许减少多样性倡议的决定相关联,引起了科学家的批评,他们声称这些削减破坏了公共健康,浪费纳税人的资源。 The cuts, part of broader funding reductions under the Trump administration and linked to a Supreme Court decision allowing reductions in diversity initiatives, have drawn criticism from scientists who say they undermine public health and waste taxpayer resources. 该机构削减间接研究成本的权力继续面临法律挑战。 Legal challenges continue over the agency’s authority to cut indirect research costs.